ClinVar Miner

Submissions for variant NM_000435.3(NOTCH3):c.4728G>C (p.Glu1576Asp)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
ARUP Laboratories, Molecular Genetics and Genomics,ARUP Laboratories RCV001287616 SCV001474322 uncertain significance none provided 2020-05-11 criteria provided, single submitter clinical testing The NOTCH3 c.4728G>C; p.Glu1576Asp variant (rs557113034), to our knowledge, is not reported in the medical literature or gene specific databases. This variant is found in the general population with an overall allele frequency of 0.0081% (21/259700 alleles) in the Genome Aggregation Database. The glutamic acid at codon 1576 is highly conserved, but computational analyses (SIFT, PolyPhen-2) predict that this variant is tolerated. Other computational splicing analyses (Alamut v.2.11) predict that this variant may impact splicing by creating a novel cryptic donor splice site, but without functional studies the effect on splicing is unknown. Most pathogenic NOTCH3 variants occur in exons 2-24 and either create or destroy a cysteine residue within an EGF-like domain (Rutten 2014). However, there are several amino acid substitutions not involving cysteine that may be disease-associated (Muino 2017). Although the p.Glu1576Asp variant does not occur within this critical region or involve a cysteine residue, due to its low population frequency and potential effects on splicing its clinical significance is uncertain. References: Muino E et al. Systematic Review of Cysteine-Sparing NOTCH3 Missense Mutations in Patients with Clinical Suspicion of CADASIL. Int J Mol Sci. 2017 Sep 13;18(9). pii: E1964. Rutten JW et al. Interpretation of NOTCH3 mutations in the diagnosis of CADASIL. Expert Rev Mol Diagn. 2014 Jun;14(5):593-603.
Athena Diagnostics Inc RCV001288086 SCV001474933 likely benign not provided 2020-01-14 criteria provided, single submitter clinical testing
Invitae RCV001288086 SCV001665110 likely benign not provided 2019-12-07 criteria provided, single submitter clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.